亞大基因科技股份有限公司
Update：2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
1. Next Generation Sequencing (NGS) testing providers scale clinical diagnostics portfolio globally
2. Clinical researchers accelerate large-scale multi-comics data processing
3. Bioinformatics developers release new analysis software products at record-b
2. Clinical researchers accelerate large-scale multi-comics data processing
3. Bioinformatics developers release new analysis software products at record-b
Founded Year
2015
Unified Business No.
24952648
Status
Active
Number of Employees
0
Total Paid-in
Capital
101,635,035 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We want to help you operationalize biomedical data, analytics, and machine learning to deliver on the promise of precision medicine.
As a data and machine learning (ML) company, we envision the cloud technology that will transform healthcare in routin
As a data and machine learning (ML) company, we envision the cloud technology that will transform healthcare in routin
